Market Research Logo

Intersect ENT Inc. (XENT) - Product Pipeline Analysis, 2016 Update

Summary

Intersect ENT Inc. (Intersect), formerly Sinexus, Inc. is a medical equipment company that offers chronic sinusitis solutions. The company offers steroid releasing implants and mini steroid implants. Its products are used in chronic sinusitis treatment such as facial pain or pressure, nasal congestion or obstruction, loss of smell or taste, headache, discolored nasal discharge, loss of sleep or fatigue and depression. Intersect provides treatment through medical therapy and sinus surgery. Intersect has developed the propel steroid-releasing implant. The company distributes its products in domestic and overseas markets. Intersect is headquartered in Menlo Park, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Intersect ENT Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Intersect ENT Inc. Company Snapshot
Intersect ENT Inc. Company Overview
Intersect ENT Inc. Pipeline Products and Clinical Trials Overview
Intersect ENT Inc. – Pipeline Analysis Overview
Key Facts
Intersect ENT Inc. - Major Products and Services
Intersect ENT Inc. Pipeline Products by Development Stage
Intersect ENT Inc. Clinical Trials by Trial Status
Intersect ENT Inc. Pipeline Products Overview
NOVA - Frontal Indication
NOVA - Frontal Indication Product Overview
NOVA - Frontal Indication Clinical Trial
NOVA- Maxillary Indication
NOVA- Maxillary Indication Product Overview
Propel Implant - Frontal Indication
Propel Implant - Frontal Indication Product Overview
Resolve- Ethmoid Sinus
Resolve- Ethmoid Sinus Product Overview
Steroid-Releasing S8 Sinus Implant
Steroid-Releasing S8 Sinus Implant Product Overview
Steroid-Releasing S8 Sinus Implant Clinical Trial
Intersect ENT Inc. - Key Competitors
Intersect ENT Inc. - Key Employees
Intersect ENT Inc. - Locations And Subsidiaries
Head Office
Recent Developments
Intersect ENT Inc., Recent Developments
Jun 01, 2016: Intersect ENT Announces Completion of Enrollment in RESOLVE II Clinical Trial of New In-Office Implant for Recurrent Chronic Sinusitis
May 16, 2016: Intersect ENT Announces Positive Clinical Results From Pivotal Study of Newest Steroid Releasing Sinus Implant
May 05, 2016: Intersect ENT Reports First Quarter 2016 Results
Mar 23, 2016: Intersect ENT Announces FDA Approval Of Additional Indication For PROPEL Mini Sinus Implant
Feb 23, 2016: Intersect ENT Reports Fourth Quarter and Year 2015 Results
Feb 22, 2016: Intersect ENT Appoints David Lehman General Counsel
Jan 29, 2016: Intersect ENT Announces NUB Status 1 Designation for PROPEL Sinus Implant in Germany
Jan 11, 2016: Intersect ENT Reports Preliminary Q4 and Year 2015 Revenue
Nov 10, 2015: Intersect ENT Announces Data Further Demonstrating Health Economic Value of PROPEL Steroid Releasing Implants
Nov 04, 2015: Intersect ENT Reports Third Quarter 2015 Results
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Intersect ENT Inc. Pipeline Products and Clinical Trials Overview
Intersect ENT Inc. Pipeline Products by Equipment Type
Intersect ENT Inc. Pipeline Products by Indication
Intersect ENT Inc. Clinical Trials by Trial Status
Intersect ENT Inc., Key Facts
Intersect ENT Inc., Major Products and Services
Intersect ENT Inc. Number of Pipeline Products by Development Stage
Intersect ENT Inc. Pipeline Products Summary by Development Stage
Intersect ENT Inc. Clinical Trials by Trial Status
Intersect ENT Inc. Clinical Trials Summary
NOVA - Frontal Indication - Product Status
NOVA - Frontal Indication - Product Description
NOVA - Frontal Indication - Pivotal Study to Evaluate the NOVA Sinus Implant
NOVA- Maxillary Indication - Product Status
NOVA- Maxillary Indication - Product Description
Propel Implant - Frontal Indication - Product Status
Propel Implant - Frontal Indication - Product Description
Resolve- Ethmoid Sinus - Product Status
Resolve- Ethmoid Sinus - Product Description
Steroid-Releasing S8 Sinus Implant - Product Status
Steroid-Releasing S8 Sinus Implant - Product Description
Steroid-Releasing S8 Sinus Implant - A Clinical Evaluation of the Safety and Efficacy of the Steroid-Releasing S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Sinus Obstruction (RESOLVE II)
Intersect ENT Inc., Key Employees
List of Figures
Intersect ENT Inc. Pipeline Products by Equipment Type
Intersect ENT Inc. Pipeline Products by Development Stage
Intersect ENT Inc. Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report